Introduction
In prenatal diagnosis of congenital orofacial clefts (OFCs), traditional methods struggle to identify pathogenic single-gene variants in non-coding regions, leaving a significant proportion of cases without clear genetic etiology. A recent study of 107 OFC fetuses demonstrated that whole exome sequencing (ES) combined with advanced bioinformatics tools, such as RDDC's RNA Splicer algorithm, can significantly improve diagnostic yield.
In this study, RDDC provided precise splicing predictions for a critical intronic variant in the CHD7 gene, which was consistently validated by minigene experiments, successfully revealing its pathogenic mechanism and enabling 11.2% of previously undiagnosed fetuses to receive molecular diagnosis.
Challenge: WES Limitations in OFCs Diagnosis and Intronic Variants
Congenital orofacial clefts (OFCs) are among the most common birth defects with complex genetic backgrounds. Although WES technology is widely applied, many cases remain undiagnosed through coding region analysis, suggesting that variants in non-coding regions such as introns may play important roles.
Case Background
This study encountered such a challenge when WES identified a splice site variant c.5535-2A>G in the intronic region of the CHD7 gene in an OFC fetus. CHD7 is the major pathogenic gene for CHARGE syndrome, but the specific functional impact of this intronic variant was unknown, requiring further analysis of its pathogenicity.
Diagnostic Gap
Traditional WES analysis primarily focuses on coding region variants, often lacking effective functional assessment methods for variants in non-coding regions such as introns. This limitation causes many potentially pathogenic variants to be overlooked, affecting the accuracy and completeness of prenatal diagnosis.
RDDC's Precise Prediction: Revealing Two Abnormal Splicing Patterns
To assess the potential impact of the c.5535-2A>G variant on RNA splicing, the research team used RDDC's RNA Splicer algorithm. RDDC's prediction results were highly specific, identifying two possible abnormal splicing consequences:
Abnormal Splicing Patterns
- Insertion of a 36 bp pseudo-exon: The variant activates a new splice acceptor site, causing a segment of intronic sequence to be erroneously included in the mature mRNA.
- 73 bp deletion in exon 27: The variant causes splicing errors, leading to partial skipping of exon 27, resulting in frameshift and premature protein termination.
Molecular Consequence Analysis
Both predictions pointed to the same conclusion: this variant would severely disrupt the normal structure and function of the CHD7 protein. CHD7 protein plays a crucial transcriptional regulatory role during embryonic development, and its functional defects directly lead to multi-system developmental abnormalities in CHARGE syndrome.
Experimental Validation: Perfect Loop from Prediction to Confirmation
The research team validated RDDC's predictions through in vitro minigene experiments. The experimental results were highly consistent with RDDC's predictions, confirming that the c.5535-2A>G variant indeed caused abnormal mRNA splicing, producing truncated CHD7 protein.
Validation Results
This finding provided clear molecular-level evidence for the fetus's severe CHARGE syndrome phenotype (such as cervical lymphatic cysts). The experimental validation not only confirmed the accuracy of RDDC's predictions but also provided reliable genetic counseling evidence for clinicians.
Clinical Significance
Through precise molecular diagnosis, physicians can provide accurate genetic risk assessment for patient families, guiding subsequent prenatal management and reproductive decisions. This complete workflow from computational prediction to experimental validation demonstrates the powerful capabilities of modern precision medicine in rare disease diagnosis.
CHD7 Gene Function and CHARGE Syndrome
The CHD7 (Chromodomain Helicase DNA-binding protein 7) gene encodes an important transcriptional regulatory factor that plays a key role during embryonic development. Functional defects in this gene are the primary cause of CHARGE syndrome.
CHARGE Syndrome Features
CHARGE syndrome is a rare multi-system developmental disorder syndrome with main features including:
- Coloboma (iris defects)
- Heart defects
- Atresia of choanae (choanal atresia)
- Retarded growth and development
- Genital abnormalities
- Ear abnormalities
Association with Orofacial Clefts
Orofacial clefts are common manifestations of CHARGE syndrome. CHD7 gene variants cause developmental abnormalities in lip, palate, and other structures by affecting transcriptional regulatory networks related to craniofacial development.
Technical Innovation and Methodological Breakthrough
This case demonstrates the technical advantages of RDDC RNA Splicer in non-coding region variant analysis. Compared to traditional splicing prediction tools, RDDC can provide more precise and detailed splicing pattern predictions.
Algorithm Advantages
- High-precision prediction: Deep learning-based algorithm models can accurately identify complex splicing patterns
- Multi-pattern analysis: Can simultaneously predict multiple possible abnormal splicing consequences
- Clinical-oriented: Prediction results directly point to specific molecular mechanisms, facilitating experimental validation
- User-friendly: Provides intuitive visualization interface and detailed result interpretation
Workflow Integration
RDDC tools can seamlessly integrate into existing WES data analysis workflows, providing powerful technical support for clinical geneticists and significantly improving detection rates and interpretation accuracy of non-coding region variants.
Case Implications: Key to Improving Non-coding Variant Detection
This case powerfully demonstrates that for WES data analysis, particularly in prenatal diagnosis scenarios, non-coding region variants cannot be ignored. Professional splicing prediction tools like RDDC RNA Splicer are key to analyzing intronic variant functions.
Diagnostic Rate Improvement
By combining WES with RDDC's precise predictions, this study successfully improved the molecular diagnosis rate of OFC fetuses by 11.2%, compensating for the shortcomings of traditional genetic testing and providing more accurate evidence for prenatal genetic counseling and prognosis assessment.
Clinical Application Value
This significant improvement in diagnostic rate has important implications for clinical practice:
- Providing clear genetic etiology explanations for more families
- Guiding individualized prenatal management strategies
- Improving accuracy and credibility of genetic counseling
- Providing evidence for risk assessment in subsequent pregnancies
Future Perspectives and Technological Development
With continuous advances in sequencing technology and ongoing optimization of bioinformatics algorithms, functional prediction of non-coding region variants will become more precise and comprehensive. The application of advanced tools like RDDC will drive prenatal diagnosis toward higher precision and broader coverage.
Technology Development Trends
- Multi-omics integration: Combining genomic, transcriptomic, and epigenetic data
- AI optimization: Using machine learning to improve prediction accuracy
- Real-time analysis: Developing rapid, automated analysis workflows
- Personalized medicine: Precise predictions based on individual genetic backgrounds
Clinical Impact
These technological advances will further improve diagnostic rates for rare diseases, bringing accurate genetic information to more patients and families, and promoting the deep application of precision medicine in prenatal diagnosis.
Conclusion
This case perfectly demonstrates RDDC RNA Splicer's outstanding performance in prenatal diagnosis of congenital orofacial clefts. Through precise prediction of the splicing consequences of the CHD7 gene c.5535-2A>G intronic variant and experimental validation, RDDC made important contributions to improving the molecular diagnosis rate of OFCs.
This successful case not only proves the scientific value of combining computational prediction with experimental validation but also points the direction for technological progress in the prenatal diagnosis field. With continuous improvement and widespread application of advanced bioinformatics tools like RDDC, we have reason to believe that more rare disease patients will benefit from precise molecular diagnosis, obtaining better medical services and quality of life.
References
Disclaimer
This article is a compilation and interpretation of the above scientific research, aimed at showcasing the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publications. The article content is for academic exchange and information dissemination only and does not constitute medical advice.
